Long-Acting Injectable Naltrexone for the Management of Patients with Opioid Dependence
, 2011 Opioid dependence is a condition with serious clinical ramifications. Treatment has focused on detoxification, agonist therapy with methadone or buprenorphine, or remission maintenance with the opioid antagonist, naltrexone.
Kimberly L. Kjome, F. Gerard Moeller
core +1 more source
Allergy, EarlyView.ABSTRACT In the last decades, critical advancements in research technology and knowledge on disease mechanisms steered therapeutic approaches for chronic inflammatory diseases towards unprecedented target specificity. For allergic and chronic lung diseases, biologic drugs pioneered this goal, acquiring on the way—through the clinical use of monoclonal ...
F. Roth‐Walter +20 more
wiley +1 more source
International Journal of COPD, 2021 Dominique Milea,1 See-Hwee Yeo,1 Yein Nam,2 Aldo Amador Navarro Rojas,1 Sumitra Shantakumar,1 Janine Beale,3 Brett Marett,3 Robert P Young,4 Raewyn J Scott,4 Barry Gribben5 1Value Evidence and Outcomes, GlaxoSmithKline plc., Greater China and ...
Milea D +9 more
doaj
Extrafine HFA-beclomethasone-formoterol vs. nonextrafine combination of an inhaled corticosteroid and a long acting β2-agonist in patients with persistent asthma: A systematic review and meta-analysis. [PDF]
PLoS One, 2021 Liu T, Yang D, Liu C.
europepmc +1 more source
Clinical effects of long-acting β2-agonists in methacholine-induced bronchoconstriction [PDF]
, 2003 In this thesis the clinical effects of long-acting β2-agonists in methacholine-induced bronchoconstriction are being investigated and discussed. the long-acting β2-agonists formoterol and salmeterol are frequently prescribed medications in the treatment ...
Woude, Hinke Johanna, van der, +1 more
core
, 2013 Bronchodilators are central drugs in the management of patients with chronic obstructive pulmonary disease (COPD). Indacaterol was the first agent of the novel family of very long-acting β2-agonists to be used as an inhaled bronchodilator for COPD and ...
RIDOLO, Erminia +4 more
core +1 more source
In Vitro Performance of Valved Holding Chambers in Paediatric Asthma Controller Therapy
Acta Paediatrica, EarlyView.ABSTRACT Aim Research on the drug delivery of inhaled corticosteroids and combination medications via valved holding chambers (VHCs) with children's breathing patterns is limited. We aimed to evaluate the in vitro performance of commercially available VHCs without facemasks under preschooler breathing conditions, focusing on total delivered dose and ...
Laura Ojanperä +2 more
wiley +1 more source
Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β2-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England. [PDF]
Int J Chron Obstruct Pulmon Dis, 2023 Czira A +12 more
europepmc +1 more source
Длительно действующие β2-агонисты в терапии бронхообструктивных заболеваний легких
, 2011 Long-acting β2-agonists in treatment of obstructive lung diseases.Длительно действующие β2-агонисты в терапии бронхообструктивных заболеваний ...
N. M. Nenasheva +1 more
core +1 more source
Alimentary Pharmacology &Therapeutics, EarlyView.A pooled analysis from the prospective UMBRELLA‐IBD registry in Germany (n = 1567) showed comparative real‐world effectiveness in treatment persistence and clinical remission of anti‐TNF, Ustekinumab and Vedolizumab in Crohn's disease patients over 24 months.
Arne Bokemeyer +7 more
wiley +1 more source